American Gene Engineer Corp (AGEC) SEC Filing 10-K Annual report for the fiscal year ending Saturday, October 31, 2015

American Gene Engineer Corp

CIK: 1600784 Ticker: AGEC
Document and Entity Information - USD ($)
12 Months Ended
Oct. 31, 2015
Feb. 02, 2016
Apr. 30, 2015
Document and Entity Information   
Entity Central Index Key0001600784  
Entity Filer CategorySmaller Reporting Company  
Amendment Flagfalse  
Document Type10-K  
Document Period End DateOct. 31, 2015  
Document Fiscal Year Focus2015  
Document Fiscal Period FocusFY  
Current Fiscal Year End Date--10-31  
Entity Well-known Seasoned IssuerNo  
Entity Voluntary FilersNo  
Entity Current Reporting StatusYes  
Entity Public Float  $ 2,147
Entity Common Stock, Shares Outstanding 100,000,000 

View differences made from one year to another to evaluate American Gene Engineer Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Gene Engineer Corp.


Assess how American Gene Engineer Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Gene Engineer Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2016 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors